Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Herman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Science Translational Medicine|September 6, 2023
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseasesJonathan D Herman, Caroline Atyeo, Yonatan Zur, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Science Translational Medicine|April 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite proteinNeville K Kisalu, Lais D Silva Pereira, Jonathan D Herman, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Science Translational Medicine|September 6, 2023
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseasesJonathan D Herman, Caroline Atyeo, Yonatan Zur, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Science Translational Medicine|April 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite proteinNeville K Kisalu, Lais D Silva Pereira, Jonathan D Herman, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Pageof 2